Medibank Expands Primary Care Network with Better Medical Acquisition
Medibank (ASX: MPL) announced its intention to purchase Better Medical, a group of 61 GP and medical centres operating throughout Victoria, Queensland, South Australia, and Tasmania, in a transaction estimated to be worth approximately AU$159 million. The move strengthens Medibank’s Amplar Health network and reinforces its commitment to advancing primary care accessibility, choice, and quality across Australia. With around 800 healthcare professionals, Better Medical will continue operating independently while enhancing its digital capabilities to streamline clinician workloads and improve patient experiences. The acquisition aligns with Medibank’s strategy to boost preventive care and community wellbeing. Expected to finalize by Q3 FY26, the deal—funded from existing capital—is projected to generate about AU$6 million in EBITDA for the six months ending June 2026. This acquisition contributes to Medibank’s broader goal of achieving AU$200 million in health segment profit and AU$700 million in employed capital by FY30, underscoring its long-term growth and healthcare innovation strategy
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Medibank Expands Primary Care Network with Better Medical Acquisition
Medibank (ASX: MPL) announced its intention to purchase Better Medical, a group of 61 GP and medical centres operating throughout Victoria, Queensland, South Australia, and Tasmania, in a transaction estimated to be worth approximately AU$159 million. The move strengthens Medibank’s Amplar Health network and reinforces its commitment to advancing primary care accessibility, choice, and quality across Australia. With around 800 healthcare professionals, Better Medical will continue operating independently while enhancing its digital capabilities to streamline clinician workloads and improve patient experiences. The acquisition aligns with Medibank’s strategy to boost preventive care and community wellbeing. Expected to finalize by Q3 FY26, the deal—funded from existing capital—is projected to generate about AU$6 million in EBITDA for the six months ending June 2026. This acquisition contributes to Medibank’s broader goal of achieving AU$200 million in health segment profit and AU$700 million in employed capital by FY30, underscoring its long-term growth and healthcare innovation strategy
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au